<unk>  is a antineoplastic biologic response modulator that is FDA approved for the treatment of . There is a Black Box Warning for this drug as shown here.  Common adverse reactions include Some adverse reactions that occur in patients undergoing treatment with<unk>  are capillary leak syndrome, nausea, fatigue, peripheral edema, pyrexia, and weight gain. Some lab abnormalities that occur include decreases in albumin, platelets, hemoglobin, calcium, sodium, and increases in glucose,ALT, and AST..
Tagraxofusp-erzs
Bromo-DragonFLY
Sdasdfadfasf
SADDAN
ISFET
Lutetium lu 177 dotatate
ITRAQ
Voretigene neparvovec